CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($) $ in Thousands	Total	Series A Preferred	Series B1 Preferred Stock	Common Stock	Common Stock Series A Preferred	Common Stock Series B1 Preferred Stock	Preferred stock Series A Preferred	Additional Paid-In Capital	Additional Paid-In Capital Series B1 Preferred Stock	Retained Earnings	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2021				63,288,000			386,000
Beginning balance at Dec. 31, 2021	$ 30,066			$ 63			$ 0	$ 138,620		$ (110,614)	$ 1,997
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)				60,000		1,113,000
Exercise of options/ B1 warrants	76		$ 0			$ 1		76	$ (1)
Stock based compensation expense	250							250
Conversion of Series A Preferred stock to common (in shares)					5,000		(5,000)
Conversion of Series A Preferred stock to common		$ 0
Equity component of the convertible note issuance, net	78,789							78,789
Accretion of redeemable non-controlling interest to redemption value	(422)									(422)
Net income (loss)	(808)									(4,547)	3,739
Less: amount attributable to redeemable non-controlling interest	(3,769)										(3,769)
Ending balance (in shares) at Mar. 31, 2022				64,466,000			381,000
Ending balance at Mar. 31, 2022	104,182			$ 64			$ 0	217,734		(115,583)	1,967
Beginning balance (in shares) at Dec. 31, 2021				63,288,000			386,000
Beginning balance at Dec. 31, 2021	30,066			$ 63			$ 0	138,620		(110,614)	1,997
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)				600,000
Net income (loss)	(64,591)
Ending balance (in shares) at Jun. 30, 2022				75,509,000			0
Ending balance at Jun. 30, 2022	97,695			$ 76			$ 0	278,455		(182,588)	1,752
Beginning balance (in shares) at Mar. 31, 2022				64,466,000			381,000
Beginning balance at Mar. 31, 2022	104,182			$ 64			$ 0	217,734		(115,583)	1,967
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)				498,000
Exercise of options/ B1 warrants	554			$ 1				553
Exercise of options to common- unissued	3							3
Distribution to non-controlling shareholder	(380)										(380)
Adjustment of redeemable non controlling interest	0							29		(29)
Stock based compensation expense	324							324
Conversion of Series A Preferred stock to common (in shares)				10,164,000	381,000		(381,000)
Conversion of Series A Preferred stock to common	59,822	$ 1		$ 10	$ 1			59,812
Accretion of redeemable non-controlling interest to redemption value	(6)									(6)
Net income (loss)	(63,782)									(66,970)	3,188
Less: amount attributable to redeemable non-controlling interest	(3,023)										(3,023)
Ending balance (in shares) at Jun. 30, 2022				75,509,000			0
Ending balance at Jun. 30, 2022	97,695			$ 76			$ 0	278,455		(182,588)	1,752
Beginning balance (in shares) at Dec. 31, 2022				75,669,000			0
Beginning balance at Dec. 31, 2022	165,420			$ 76			$ 0	279,552		(115,893)	1,685
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)				166,000
Exercise of options/ B1 warrants	209							209
Stock based compensation expense	365							365
Non controlling shareholder contribution	980										980
Net income (loss)	53,813									53,863	(50)
Ending balance (in shares) at Mar. 31, 2023				75,835,000			0
Ending balance at Mar. 31, 2023	220,787			$ 76			$ 0	280,126		(62,030)	2,615
Beginning balance (in shares) at Dec. 31, 2022				75,669,000			0
Beginning balance at Dec. 31, 2022	165,420			$ 76			$ 0	279,552		(115,893)	1,685
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)				400,000
Net income (loss)	(27,641)
Ending balance (in shares) at Jun. 30, 2023				93,237,000			0
Ending balance at Jun. 30, 2023	241,490			$ 93			$ 0	381,776		(143,431)	3,052
Beginning balance (in shares) at Mar. 31, 2023				75,835,000			0
Beginning balance at Mar. 31, 2023	220,787			$ 76			$ 0	280,126		(62,030)	2,615
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)				195,000
Exercise of options/ B1 warrants	169							169
Stock based compensation expense	368							368
Senior Note Converted (in shares)				17,207,000
Senior Note Converted	101,130			$ 17				101,113
Non controlling shareholder contribution	490										490
Net income (loss)	(81,454)									(81,401)	(53)
Ending balance (in shares) at Jun. 30, 2023				93,237,000			0
Ending balance at Jun. 30, 2023	$ 241,490			$ 93			$ 0	$ 381,776		$ (143,431)	$ 3,052